ZA991641B - Treatment of viral disease in swine. - Google Patents
Treatment of viral disease in swine.Info
- Publication number
- ZA991641B ZA991641B ZA9901641A ZA991641A ZA991641B ZA 991641 B ZA991641 B ZA 991641B ZA 9901641 A ZA9901641 A ZA 9901641A ZA 991641 A ZA991641 A ZA 991641A ZA 991641 B ZA991641 B ZA 991641B
- Authority
- ZA
- South Africa
- Prior art keywords
- swine
- treatment
- viral disease
- viral
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7646698P | 1998-03-02 | 1998-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991641B true ZA991641B (en) | 2000-09-01 |
Family
ID=22132217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901641A ZA991641B (en) | 1998-03-02 | 1999-03-01 | Treatment of viral disease in swine. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6034070A (https=) |
| EP (1) | EP0948967B1 (https=) |
| JP (1) | JP4555472B2 (https=) |
| AT (1) | ATE281173T1 (https=) |
| AU (1) | AU2979899A (https=) |
| CA (1) | CA2322327C (https=) |
| CO (1) | CO5080775A1 (https=) |
| DE (1) | DE69921530T2 (https=) |
| DK (1) | DK0948967T3 (https=) |
| ES (1) | ES2230802T3 (https=) |
| MY (1) | MY124071A (https=) |
| PT (1) | PT948967E (https=) |
| SI (1) | SI0948967T1 (https=) |
| TW (1) | TW565452B (https=) |
| WO (1) | WO1999044619A1 (https=) |
| ZA (1) | ZA991641B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506885B1 (en) * | 2001-09-27 | 2003-01-14 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| ES2561108T3 (es) * | 2001-10-19 | 2016-02-24 | Idexx Laboratories, Inc. | Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo |
| SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
| US7282487B2 (en) * | 2004-10-28 | 2007-10-16 | Idexx Laboratories | Method for treating bacterial infections in horses or pigs with tilmicosin |
| CA2657483C (en) | 2006-07-28 | 2012-10-09 | Intervet International B.V. | Macrolide synthesis process |
| CN103288904B (zh) * | 2013-06-28 | 2015-07-15 | 宁夏泰瑞制药股份有限公司 | 一种磷酸替米考星晶体的制备方法 |
| CN103483406A (zh) * | 2013-09-25 | 2014-01-01 | 宁夏泰瑞制药股份有限公司 | 一种磷酸替米考星的制备方法 |
| CN103923141B (zh) * | 2014-04-21 | 2016-04-27 | 西南大学 | 一种依托替米考星的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820695A (en) * | 1982-09-13 | 1989-04-11 | Eli Lilly And Company | C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics |
| AU561147B2 (en) * | 1982-09-13 | 1987-04-30 | Eli Lilly And Company | 20-amino macrolide antibiotics |
| US5574020A (en) * | 1989-09-28 | 1996-11-12 | Eli Lilly And Company | Tilmicosin formulation |
| US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
| GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
| EP0732340B1 (en) * | 1995-03-14 | 2004-06-09 | Akzo Nobel N.V. | Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
-
1999
- 1999-03-01 ZA ZA9901641A patent/ZA991641B/xx unknown
- 1999-03-01 AT AT99301503T patent/ATE281173T1/de active
- 1999-03-01 EP EP99301503A patent/EP0948967B1/en not_active Expired - Lifetime
- 1999-03-01 PT PT99301503T patent/PT948967E/pt unknown
- 1999-03-01 DK DK99301503T patent/DK0948967T3/da active
- 1999-03-01 SI SI9930730T patent/SI0948967T1/xx unknown
- 1999-03-01 ES ES99301503T patent/ES2230802T3/es not_active Expired - Lifetime
- 1999-03-01 CO CO99012471A patent/CO5080775A1/es unknown
- 1999-03-01 MY MYPI99000736A patent/MY124071A/en unknown
- 1999-03-01 DE DE69921530T patent/DE69921530T2/de not_active Expired - Lifetime
- 1999-03-01 TW TW088103069A patent/TW565452B/zh not_active IP Right Cessation
- 1999-03-01 US US09/259,780 patent/US6034070A/en not_active Expired - Lifetime
- 1999-03-02 WO PCT/US1999/004621 patent/WO1999044619A1/en not_active Ceased
- 1999-03-02 JP JP2000534220A patent/JP4555472B2/ja not_active Expired - Fee Related
- 1999-03-02 AU AU29798/99A patent/AU2979899A/en not_active Abandoned
- 1999-03-02 CA CA002322327A patent/CA2322327C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0948967B1 (en) | 2004-11-03 |
| WO1999044619A1 (en) | 1999-09-10 |
| AU2979899A (en) | 1999-09-20 |
| JP4555472B2 (ja) | 2010-09-29 |
| EP0948967A3 (en) | 1999-10-20 |
| DE69921530D1 (de) | 2004-12-09 |
| DE69921530T2 (de) | 2005-10-27 |
| PT948967E (pt) | 2005-02-28 |
| SI0948967T1 (en) | 2005-06-30 |
| ES2230802T3 (es) | 2005-05-01 |
| ATE281173T1 (de) | 2004-11-15 |
| TW565452B (en) | 2003-12-11 |
| MY124071A (en) | 2006-06-30 |
| EP0948967A2 (en) | 1999-10-13 |
| CA2322327C (en) | 2009-12-22 |
| US6034070A (en) | 2000-03-07 |
| CA2322327A1 (en) | 1999-09-10 |
| JP2002505294A (ja) | 2002-02-19 |
| CO5080775A1 (es) | 2001-09-25 |
| DK0948967T3 (da) | 2005-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
| PL341364A1 (en) | 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents | |
| GB0025173D0 (en) | Therapeutic agents | |
| GB0005251D0 (en) | Therapeutic compounds | |
| DE60031396D1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
| WO2002002518A3 (en) | Compounds to treat alzheimer's disease | |
| WO2002002520A8 (en) | Compounds to treat alzheimer's disease | |
| SE9604786D0 (sv) | New compounds | |
| HU9600834D0 (en) | Quinazoline derivatives | |
| EP0896533A4 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
| EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
| HU901585D0 (en) | Method for treatment of viral infections using functional derivatives of icam-1 | |
| EP0278174A3 (en) | Use of fluticasone propionate in the treatment of bowel diseases | |
| IL119207A0 (en) | Treatment of tinnitus using neuroprotective agents | |
| NL960024I2 (nl) | Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten. | |
| ZA991641B (en) | Treatment of viral disease in swine. | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| BR0012921A (pt) | Compostos calcilìticos | |
| ATE141796T1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
| TR199802200A2 (xx) | S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi. | |
| IT216694Z2 (it) | Manopola monouso, per l'igiene personale di pazienti in genere. | |
| BG101145A (bg) | Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа | |
| ES2078380T3 (es) | Oligofosfatos de accion antiviral. | |
| LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
| DE68914886D1 (de) | Mittel zur Behandlung von Raynaud's Krankheit. |